Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Category Archives: Advertising
Live from DIA: FDA Warning Letters Stir More Questions Than Answers
A panel of regulators from FDA’s Division of Drug Marketing, Advertising, and Communications were taken to task, this morning at the Drug Information Association’s annual meeting, for 14 warning letters levied on drug companies for not including risk information in online search ads.
A Sanofi Aventis employee complained about the 14 warning letters and asked why [...]
Also posted in Regulatory Tagged DDMAC, DIA, FDA, Marketing, new media, Search, Warning Letters 1 Comment
Traditional vs. Digital, or
Integrate! Integrate! Integrate!
Can pharma rely on one agency to create both its traditional and its interactive advertising? Or is there a “best agency model” (pure digital, digital group within larger holding company, or a mixture of both) that industry can follow? This was the question addressed by four panelists today at the ePharma Summit in Philadelphia.
Bill [...]
Also posted in E-Media, Marketing Tagged e-marketing, Eli Lilly, ePharma Summit, Extrovertic, Heartbeat Digital, Saatchi & Saatchi 5 Comments
Distractions Abound – DTC Perspectives Day 2
Andy Levitt of HealthTalker checks in with a report from day 2 of the DTC Perspectives conference in New Jersey.
I had to laugh. And you would, too.
I looked around the room as the clock approached noon today during Day 2 of the Fall DTC Perspectives conference. I was amazed by the amount of distraction that [...]
Also posted in E-Media, Events Tagged Advertisements, consumer choice, DTC Perspectives, ICC Trio, Mike Bloxham, Pharma, Tom Clark 1 Comment

Building a Better Brief Summary